Advances in biomarkers of IgA nephropathy Hailang Wei1, Fuhua Xie2, Runxiu Wang1 1 Department of Nephrology, The First Affiliated Hospital, and 2 School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, China
DOI 10.5414/CN111395
Abstract
IgA nephropathy (IgAN) is the most common primary glomerular disease in the world; it is associated with the intestinal microbiota, diet, genetics, etc., and is mainly diagnosed by kidney biopsy. Patients with IgAN may develop end-stage renal disease (ESRD) within decades of diagnosis, placing an enormous burden on patients and society. Therefore, early prediction and effective measures are needed to prevent disease progression. To date, a large number of studies have explored biomarkers of IgAN progression. In this paper, IgAN biomarkers are discussed to guide the early diagnosis, prevention, and treatment of this disease.
1 Department of Nephrology, The First Affiliated Hospital, and
2 School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, China
Address
Runxiu Wang, MD
Department of Nephrology
The First Affiliated Hospital
Gannan Medical University
Ganzhou 341000, Jiangxi, China
or
Fuhua Xie, MD, PhD
School of Basic Medicine
Gannan Medical University
Ganzhou 341000, Jiangxi, China Email: [email protected]
Citation
Hailang Wei, Fuhua Xie, Runxiu Wang.Advances in biomarkers of IgA nephropathy .Clin Nephrol.2026; 105: 48-55. doi: 10.5414/CN111395. Pubmed: https://pubmed.ncbi.nlm.nih.gov/41126584/; PMID: 41126584.
during a check of our data we have observed, that we don't have your current E-Mail address on file. We would like to ask you to send it to us, in case we need to contact you. You can send us an E-Mail to [email protected] or call us under +49-89-613861-0.
